Lugano, Switzerland (ots/PRNewswire) - ~ 40 years helping patients achieve a better quality of life ~ Helsinn, the Swiss pharmaceutical Group focused on building quality cancer care, is delighted to launch its 40th anniversary celebrations in San Francisco, US, at the time of the JP Morgan 34th Annual Healthcare Conference. Helsinn believes its core values of respect, integrity and quality have underpinned four decades of ...
London (ots/PRNewswire) - ViiV Healthcare, a global specialist HIV company with GSK, Pfizer Inc. and Shionogi Limited as shareholders, today formalised its collaboration with Janssen Sciences Ireland UC (Janssen) for the phase III investigation and commercialisation of the long-acting, injectable formulations of ...
Cork, Ireland (ots/PRNewswire) - Results from ongoing phase IIb Week 32 study show that if successfully developed and approved, people living with HIV could potentially maintain viral suppression Janssen Sciences Ireland UC (Janssen), today formalized its collaboration with ViiV Healthcare on phase III development ...
Heidelberg (ots) - BioMed X Innovation Center announced today that they have entered into a collaboration agreement with Johnson & Johnson Consumer, Inc. seeking to establish a research group to focus on the development of novel methods for the disruption of oral biofilms. This collaboration was facilitated by ...
Darmstadt, Germany (ots/PRNewswire) - - Merck becomes first pharmaceutical company to collaborate with multiple diagnostic providers to support RAS biomarker testing - Collaboration allows Merck to provide complementary molecular testing solutions to various laboratory segments - Biocartis' fully automated Idylla(TM) system will enable more clinics to assess RAS ...
Uithoorn, The Netherlands (ots/PRNewswire) - HOYA Vision Care Company, a key player in the global market for ophthalmic lenses, announces the establishment of HOYA Lens RUS LLC. Building on a strong position in the Russian Federation through a longtime local distributor, HOYA is now entering the market directly to provide better service and further develop its customer base. HOYA sees significant opportunities to expand ...
Raritan, New Jersey (ots/PRNewswire) - New approach for early treatment and interception of HPV-induced cancers Janssen Pharmaceuticals, Inc. (Janssen) announced today that the company has entered into a definitive collaboration and license agreement with Bavarian Nordic to leverage their MVA-BN® technology, ...
Lausanne, Switzerland (ots/PRNewswire) - Debiopharm International SA (Debiopharm), part of Debiopharm Group(TM), a Swiss-based global biopharmaceutical company, today announced that the European Medicines Agency (EMA) granted Orphan Drug Designation to Debio 1143 for treatment of Ovarian Cancer affecting around 154 ...
Kuwait Foundation for the Advancement of Sciences
Kuwait City, Kuwait (ots/PRNewswire) - Kuwait today launched a major initiative to spur sustainable development across Africa with an annual prize recognizing the best research or development advances in food security, health and education that contribute to significantly solving development challenges facing ...
Darmstadt, Germany (ots/PRNewswire) - Not intended for UK-based media - Despite signs of activity in locally advanced and metastatic pancreatic cancer, two Phase III studies did not meet pre-specified primary endpoints - Merck will focus efforts on more promising candidates in pipeline Merck, a leading science and ...
Mandaluyong, Philippines and Lausanne, Switzerland (ots/PRNewswire) - Pamorelin® one-, three- and six-month dosing option now available to patients in the Philippines United Laboratories Inc. (Unilab) and Debiopharm International SA (Debiopharm) announce the signature of an exclusive agreement for the distribution ...
London (ots/PRNewswire) - Contract to support up to 6,000 users at 400 sites worldwide for Defence Medical Services, enhancing CGI's existing service, which began in 2006 Stock Market Symbols GIB (NYSE) GIB.A (TSX) http://www.cgi.com/newsroom CGI (NYSE: GIB) (TSX: GIB.A) has been selected to provide an integrated electronic health record (iEHR) service for the UK ...
Vancouver, British Columbia (ots/PRNewswire) - This material is intended for global medical media only. This material is not approved for Canadian journalists or Canadian audiences. For journalistic assessment and preparation before publication. Abstracts 0336-P, 0337-P, 0338-P New analyses demonstrate that ...
Vancouver, Canada (ots/PRNewswire) - This material is intended for global medical media only. This material is not approved for Canadian journalists or Canadian audiences. For journalistic assessment and preparation before publication. Results from the Perceptions of Control (POC) study showed that people with type ...
Vancouver, Canada (ots/PRNewswire) - This material is intended for global medical media only. This material is not approved for Canadian journalists or Canadian audiences. For journalistic assessment and preparation before publication. Abstracts: 0720-P, 0721-P, 1074-P, 0956-P New data from four analyses[1],[2],[3],[4] demonstrate that post-meal hyperglycaemia (when ...
Vancouver, Canada (ots/PRNewswire) - This material is intended for global medical media only. This material is not approved for Canadian journalists or Canadian audiences. For journalistic assessment and preparation before publication. New findings from a network meta-analysis show that treatment with Victoza® (liraglutide) provides a greater HbA1c reduction and an ...
JTI Japan Tobacco International AG
Geneva (ots/PRNewswire) - Delayed Report Prompts Concern Over Compliance On the third anniversary of Australia's controversial 'plain' packaging legislation for tobacco products, the Government is still refusing to admit its failure. This would explain why the Department of Health (DoH) is pushing back the publication of its Post-Implementation Review (PIR). (Logo: ...
Sunnyvale, California (ots/PRNewswire) - Erasmus MC Team Hosts Clinicians from Around-the-World at Fully-Subscribed Course Accuray Incorporated (Nasdaq: ARAY) announced the second course of the European School of Robotic Stereotactic Radiotherapy at Erasmus MC Center Institute, Rotterdam, The Netherlands, following ...
Nuremberg, Germany (ots/PRNewswire) - With the pressure of Christmas shopping already underway, GfK has released findings from a 22-country survey looking at the major causes of stress in people's daily lives. Money, self-pressure and lack of sleep are the top three major causes of stress internationally. Latin American countries stand out for 'threat of crime' ...
Lausanne, Switzerland (ots/PRNewswire) - Debiopharm International SA (Debiopharm), part of Debiopharm Group(TM), a Swiss-based global biopharmaceutical company, is proud to congratulate its partner Yakult's commitment in obtaining approval for a supplemental new drug application for Elplat® in postoperative ...
Alios BioPharma, Inc., part of the Janssen Pharmaceutical Companies
San Francisco (ots/PRNewswire) - - ALS-008176 now being evaluated in RSV-infected infants - Alios BioPharma, Inc., part of the Janssen Pharmaceutical Companies announced that the New England Journal of Medicine (NEJM) will publish findings from a respiratory syncytial virus (RSV) challenge study for ALS-008176, a ...
Reading, Massachusetts (ots/PRNewswire) - Change reflects the company's evolution to a strategic partner, delivering data-driven digital and mobile health engagement campaigns that empower better decisions and drive business results Physicians Interactive today announced that it has become Aptus Health (http://www.aptushealth.com/), reflecting its mission of advancing ...
Amsterdam (ots/PRNewswire) - - 2.5 year scientific evaluation of European integrated care programs and 2,500 surveys provide unparalleled insights on success factors of connected care programs across the European Union - Advanced Care Coordination and Telehealth Deployment (ACT) program addresses EU's aging ...
Ballerup, Denmark (ots/PRNewswire) - LEO Pharma A/S, a global healthcare company dedicated to helping people achieve healthy skin, and Japanese pharmaceutical company Astellas Pharma Inc. today announced that they have entered into an Asset Purchase Agreement under which Astellas will transfer its global dermatology business to LEO Pharma for EUR 675 million. (Logo: ...
Milan (ots/PRNewswire) - Abstract: PDB54 B20 New findings from a health economics and outcomes research (HEOR) analysis demonstrated that Victoza® (liraglutide) 1.2 mg is cost-effective for the treatment of type 2 diabetes in the UK market when compared to lixisenatide and is cost-saving compared to exenatide.[1] ...
Lyon, France (ots/PRNewswire) - The European Medicine Agency's Pharmacovigilance Risk Assessment Committee (PRAC) concludes that there is no reason to change the way the vaccines are used or amend the current product information. Sanofi Pasteur MSD welcomes the European Medicine Agency's Pharmacovigilance Risk ...
Doha, Qatar (ots/PRNewswire) - Dr. Sakena Yacoobi, Founder and Executive Director of the Afghan Institute of Learning (AIL) has been named the 2015 WISE Prize for Education Laureate. Popularly known as Afghanistan's mother of education, Dr.Yacoobi, 65, has spent two decades working persistently to rebuild her country's education landscape, devastated by war. The WISE Prize for Education was presented by Her Highness ...
Dublin And Marlow, England (ots/PRNewswire) - - Complements Allergan's leadership position in Medical Aesthetics and enhances offering to Plastic Surgeons - earFold(TM), for the correction of prominent ears and/or ear asymmetry in people aged 7 years and older,[1] was recently granted a CE mark for commercialisation in Europe - A minimally-invasive treatment ...
London (ots/PRNewswire) - ViiV Healthcare, a global specialist HIV company with GSK, Pfizer Inc. and Shionogi Limited as shareholders, today announced that the Phase IIb study LATTE 2 (NCT02120352) met its primary endpoint at 32 weeks. These results show that the investigational, long acting, injectable formulations ...
Cork, Ireland (ots/PRNewswire) - Injectable combinations once every 4 or 8 weeks show comparable efficacy versus daily oral combination therapy Janssen Sciences Ireland UC, one of the Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen), announced that Phase IIb data studying a combination regimen of ...